THE INCLASS STUDY (on-going study)

INCLASS is a randomized clinical trial aiming to compare the efficacy of intravenous clarithromycin over placebo in patients with sepsis and respiratory failure.

Study title: “A double-blind, randomized, placebo-controlled clinical study of the efficacy of INtravenous CLArithromycin as adjunctive treatment in patients with Sepsis and respiratory and multiple organ dysfunction Syndrome” NCT03296423
EudraCT number 2017-001056-55
National Organization for Medicines Approval: IS-64/17
National Ethics Committee Approval: 64/17
Study phase: IV
Study sites: 9 sites in Greece and in 4 sites in Belgium
Target of enrolment: 110 patients
Starting date: January 2018
Anticipated end date: December 2019